Table 1.
Clinical applications of partial ROS-related ncRNAs in cancer patients
| NcRNA | Type | Cancer | Application | Status | Identifier |
|---|---|---|---|---|---|
| MiR-373 | NA | Breast cancer | Cancer diagnosis | Recruiting | NCT04720508 |
| MiR-155 | NA | Bladder cancer | Cancer diagnosis | Completed | NCT03591367 |
| MiR-371 | NA | Germ cell cancer | Cancer diagnosis | Recruiting | NCT04435756 |
| HOTAIR | NA | Thyroid cancer | Cancer diagnosis | Unknown | NCT03469544 |
| MiR-16 | Mimic | Pleural mesothelioma lung cancer | Cancer therapy | Phase I | NCT02369198 |
| MiR-122 | ASO | Liver cancer | Cancer therapy | Phase I/II | NCT01646489, NCT01727934, NCT01872936, NCT01200420 |
| MiR-155 | ASO | T-cell lymphoma | Cancer therapy | Phase II | NCT03713320, NCT03713320 |
| MiR-34a | Mimic | Melanoma | Cancer therapy | Phase I | |
| MtlncRNA | ASO | Unresectable tumors | Cancer therapy | Phase I |